Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Chronic Pain, Cognitive Studies, Cognitive Studies |
| Therapuetic Areas: | Musculoskeletal, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/6/2019 |
| Start Date: | November 7, 2012 |
| End Date: | December 15, 2019 |
MC1193: Collaborative Care to Preserve Performance in Cancer (COPE)
This randomized clinical trial studies collaborative targeted case management in improving
functional status in patients with stage III-IV cancer. Collaborative targeted case
management may improve functional mobility, improve quality of life, and reduce pain and
health care utilization in patients with advanced cancer
functional status in patients with stage III-IV cancer. Collaborative targeted case
management may improve functional mobility, improve quality of life, and reduce pain and
health care utilization in patients with advanced cancer
PRIMARY OBJECTIVES:
I. Establish the comparative effectiveness of the Collaborative Care to Preserve Performance
in Cancer (COPE) trial arms in preserving functional mobility.
II. To assess the comparative cost-effectiveness and cost-utility of the COPE interventions.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I: Patients undergo enhanced usual care comprising telephonic monitoring with monthly
status reports provided to their oncology care teams for 6 months.
ARM II: Patients undergo enhanced usual care as in Arm I and participate in an individualized
conditioning program delivered telephonically by the Fitness Care Manager (FCM) and adapted,
as required, by a local physical therapist for 6 months.
ARM III: Patients undergo enhanced usual care as in Arm I, participate in an individualized
conditioning program coordinated by the FCM as in Arm II, and receive optimized pain
management through a nurse Pain Care Manager (PCM) for 6 months.
I. Establish the comparative effectiveness of the Collaborative Care to Preserve Performance
in Cancer (COPE) trial arms in preserving functional mobility.
II. To assess the comparative cost-effectiveness and cost-utility of the COPE interventions.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I: Patients undergo enhanced usual care comprising telephonic monitoring with monthly
status reports provided to their oncology care teams for 6 months.
ARM II: Patients undergo enhanced usual care as in Arm I and participate in an individualized
conditioning program delivered telephonically by the Fitness Care Manager (FCM) and adapted,
as required, by a local physical therapist for 6 months.
ARM III: Patients undergo enhanced usual care as in Arm I, participate in an individualized
conditioning program coordinated by the FCM as in Arm II, and receive optimized pain
management through a nurse Pain Care Manager (PCM) for 6 months.
Inclusion Criteria:
- Diagnosis of stage III or stage IV cancer
- Life expectancy > 6 months
- Ambulatory Post Acute Care (APC) score between 53 and 66
- Ability to complete questionnaire(s) by themselves or with assistance
- Provide informed written consent
- Have working phone to communicate with study team
- Fluent in English
- Sufficient auditory acuity
- Intact cognitive status
Exclusion Criteria:
- Patient is within 2 months of a major surgical procedure
We found this trial at
1
site
Click here to add this to my saved trials
